CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $1.8M of Corcept Therapeutics Incorporated
Sold$1,848,890
$113.43Price
16,300Shares
−80%Stake
What CORT did after the filing
- The stock from Thu, Aug 13 open, $112.53
- +2.8%
- S&P 500, same days
- −1.2%
Measured over 30 trading days, to the Sep 28 close.
Traded Mon, Aug 10. Filed Wed, Aug 12, 4:26 PM ET, after the close. Returns use the Aug 13 open and the Sep 28 close. Not investment advice.